Inhibition of 11β-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells

Journal of Endocrinology

Volumn 155, Issue 1, 1997, Pages 171-180

  Hundertmark, S ^a   Buhler H ^a   Rudolf, M ^a   Weitzel, H K ^a   Ragosch, V ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; AMINOGLUTETHIMIDE; CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID; GLYCYRRHIZIC ACID; PREDNISOLONE; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; DRUG ANTAGONISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEEDBACK SYSTEM; HORMONAL THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADMINISTRATION, TOPICAL; AMINOGLUTETHIMIDE; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL DIVISION; CELLS, CULTURED; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; GLYCYRRHETINIC ACID; HUMANS; HYDROXYSTEROID DEHYDROGENASES; PREDNISOLONE; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 1842326161     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1550171     Document Type: Article

References (56)

1. Abe H, Ohya N, Yamamoto KF, Shibuya T, Arichi S & Odashima S 1987 Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells. European Journal of Cancer and Clinical Oncology 23 1549-1555.
2. Abramovitz M, Carriero R & Murphy BE 1984 Investigation of factors influencing 11 beta-hydroxysteroid dehydrogenase (EC 1.1.1.146) activity in midgestational human Fetal lung monolayer and explant cultures. Journal of Steroid Biochemistry 21 677-683.
3. Agarwal R, Wang ZY & Mukhtar H 1991 Inhibition of mouse skin tumor-initiating activity of DMBA by chronic oral feeding of glycyrrhizin in drinking water. Nutrition and Cancer 15 187-193.
4. Agarwal AK, Mune T, Monder C & White PC 1994 NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. Journal of Biological Chemistry 269 25959-25962.
5. Brem AS, Matheson KL, Conca T & Morris DJ 1989 Effect of carbenoxolone on glucocorticoid metabolism and Na transport in toad bladder. American Journal of Physiology 257 F700-F704.
6. Buhler H 1993a The intracellular glucocorticoid metabolism by 11β-hydroxysteroid dehydrogenase in MDCK cells is enhanced by preincubation with dexamethasone. Nieren und Hochdruckkrankheiten 22 470.
7. Buhler H 1993b Enhancement of intracellular cAMP levels reduces the oxidative activity of 11β-hydroxysteroid dehydrogenase (11β-HSD) in HT-29 human colon carcinoma cells. Pflügers Archives 424 R86.
8. Buhler H, Perschel FH, Fitzner R & Hierholzer K 1994 Endogenous inhibitors of 11 beta-OHSD: existence and possible significance. Steroids 59 131-135.
9. Castiglione Gertsch M, Johnsen C, Goldhirsch A, Gelber RD, Rudenstam CM, Collins J, Lindtner J, Hacking A, Cortes Funes H, Forbes J et al. 1994 The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up. Annals of Oncology 5 717-724.
10. Coleman RE 1992 Glucocorticoids in cancer therapy. Biotherapy 4 37-44.
11. DiMartino L, Demontis B, Mitchell IP, Hayward SW & Deshpande N 1991 A randomized clinical trial to investigate the usefulness of the addition of prednisolone to tamoxifen as adjuvants to mastectomy in primary breast cancer patients with a high risk of recurrence: a preliminary report. AntiCancer Research 11 869-872.
12. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER & Monder C 1988 Localisation of 11 beta-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet ii 986-989.
13. Fentiman IS, Howell A, Hamed H, Lee SM, Ranson M, Wall J, Chaudary MA, Ash CM, Gregory WM, Sellwood RA et al. 1994 A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer. British Journal of Cancer 70 729-731.
14. Funder JW, Pearce PT, Smith R & Smith AI 1988 Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242 583-585.
15. Goya L, Maiyar AC, Ge Y & Firestone GL 1993 Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha. Molecular Endocrinology 7 1121-1132.
16. Hammami MM & Siiteri PK 1991 Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. Journal of Clinical Endocrinology and Metabolism 73 326-334.
17. Hierholzer K, Siebe H & Fromm M 1990 Inhibition of 11 beta-hydroxysteroid dehydrogenase and its effect on epithelial sodium transport. Kidney International 38 673-678.
18. Hundertmark S, Ragosch V, Schein B, Buhler H, Lorenz U, Fromm M & Weitzel HK 1994 Gestational age dependence of 11 beta-hydroxysteroid dehydrogenase and its relationship to the enzymes of phosphatidylcholine synthesis in lung and liver of fetal rat. Biochimica et Biophysica Acta 1210 348-354.
19. Hundertmark S, Buhler H, Ragosch V, Dinkelborg L, Arabin B & Weitzel HK 1995 Correlation of surfactant phosphatidylcholine synthesis and 11 beta-hydroxysteroid dehydrogenase in the fetal lung. Endocrinology 136 2573-2578.
20. Ingle JN, Mailliard JA, Schaid DJ, Krook JE, Gesme DH Jr, Windschitl HE, Pfeifle DM, Etzell PS, Gerstner JG, Long HJ et al. 1991 A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic. Cancer 68 34-39.
21. Kapturczak M, Bühler H, Lichtenstein I & Hierholzer K 1992 Isoforms of 11β-hydroxysteroid dehydrogenase (11β-HSD) activity along the mouse nephron. Pflügers Archives 420 R73.
22. Kumagi A, Yano S, Otomo M & Takeuchi K 1957 Study on the corticoid-like action of glycyrrhizin and the mechanism of its action. Endocrinologia Japonica 4 17-27.
23. Labrie F, Poulin R, Simard J, Zhao HF, Labrie C, Dauvois S, Dumont M, Hatton AC, Poirier D & Merand Y 1990 Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells. Annals of the New York Academy of Sciences 595 130-148.
24. Lippman M, Bolan G & Huff K 1976 The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. Cancer Research 36 4602-4609.
25. Lonka L & Smith R 1987 How liquorice works. Lancet ii 1206-1207.
26. Mashiba H & Matsunaga K 1990 Augmented antiproliferative effect of tumor necrosis factor (TNF), lymphotoxin and glycyrrhizin in combined use with diethyldithiocarbamate on Meth A tumor cells in vitro. Japanese Journal of Experimental Medicine 60 67-71.
27. Monder C 1993 The forms and functions of 11 beta-hydroxysteroid dehydrogenase. Journal of Steroid Biochemistry and Molecular Biology 45 161-165.
28. Monder C & Shackleton CH 1984 11 Beta-hydroxysteroid dehydrogenase: fact or fancy? Steroids 44 383-417.
29. Monder C, Shackleton CH, Bradlow HL, New MI, Stoner E, Iohan F & Lakshmi V 1986 The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism. Journal of Clinical Endocrinology and Metabolism 63 550-557.
30. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D & Edwards CR 1989 Licorice inhibits corticosteroid 11 beta-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology 125 1046-1053.
31. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. Journal of Immunology Methods 65 55-63.
32. Nath N, Lakshmi V & Rosenthal JC 1993 Presence of 11 beta-hydroxysteroid dehydrogenase enzyme in the human prostate tumor cell line LNCaP. Prostate 23 225-233.
33. Nishino H, Yoshioka K, Iwashima A, Takizawa H, Konishi S, Okamoto H, Okabe H, Shibata S, Fujiki H & Sugimura T 1986 Glycyrrhetic acid inhibits tumor-promoting activity of teleocidin and 12-O-tetradecanoylphorbol-13-acetate in two-stage mouse skin carcinogenesis. Japanese Journal of Cancer Research 77 33-38.
34. Okimasu E, Moromizato Y, Watanabe S, Sasaki J, Shiraishi N, Morimoto YM, Miyahara M & Utsumi K 1983 Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug. Acta Medica Okayama 37 385-391.
35. Osborne CK, Monaco ME, Kahn CR, Huff K, Bronzert D & Lippman ME 1979 Direct inhibition of growth and antagonism of insulin action by glucocorticoids in human breast cancer cells in culture. Cancer Research 39 2422-2428.
36. Page N, Warriar N & Govindan MV 1994 11 Beta-hydroxysteroid dehydrogenase and tissue specificity of androgen action in human prostate cancer cell LNCaP. Journal of Steroid Biochemistry and Molecular Biology 49 173-181.
37. Penning TM & Ricigliano JW 1991 Mechanism based inhibition of hydroxysteroid dehydrogenases. Journal of Enzyme Inhibition 5 165-198.
38. Poulin R, Baker D, Poirier D & Labrie F 1991 Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids. Breast Cancer Research and Treatment 17 197-210.
39. Quirk SJ, Slattery J & Funder JW 1990a 11 Beta-hydroxysteroid dehydrogenase activity in the mammary gland. Journal of Steroid Biochemistry 35 623-625.
40. Quirk SJ, Slattery JA & Funder JW 1990b Epithelial and adipose cells isolated from mammary glands of pregnant and lactating rats differ in 11 beta-hydroxysteroid dehydrogenase activity. Journal of Steroid Biochemistry and Molecular Biology 37 529-534.
41. Reeves WB 1995 NAD-dependent 11 beta-hydroxysteroid dehydrogenase in cultured human colonic epithelial cells. American Journal of Physiology 268 C1467-C1473.
42. Roy AK 1992 Regulation of steroid hormone action in target cells by specific hormone-inactivating enzymes. Proceedings of the Society for Experimental Biology and Medicine 199 265-272.
43. Rubens RD, Tinson CL, Coleman RE, Knight RK, Tong D, Winter PJ & North WR 1988 Prednisolone improves the response to primary endocrine treatment for advanced breast cancer (see comments). British Journal of Cancer 58 626-630.
44. Siebe H, Baude G, Lichtenstein I, Wang D, Buhler H, Hover GA & Hierholzer K 1993 Metabolism of dexamethasone: sites and activity in mammalian tissues. Renal Physiology and Biochemistry 16 79-88.
45. Simard J, de Launoit Y, Haagensen DE & Labrie F 1992 Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. Endocrinology 130 1115-1121.
46. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ & Klenk DC 1985 Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150 76-85.
47. Stewart JF, Rubens RD, King RJ, Minton MJ, Steiner R, Tong D, Winter PJ, Knight RK & Hayward JL 1982 Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer. European Journal of Cancer and Clinical Oncology 18 1307-1314.
48. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH & Edwards CR 1987 Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet ii 821-824.
49. Stewart PM, Corrie JE, Shackleton CH & Edwards CR 1988 Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. Journal of Clinical Investigation 82 340-349.
50. Suzuki F, Schmitt DA, Utsunomiya T & Pollard RB 1992 Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots. In Vivo 6 589-596.
51. Takahashi K, Shibata S, Yano S, Harada M, Saito H, Tamura Y & Kumagai A 1980 Chemical modification of glycyrrhetinic acid in relation to the biological activities. Chemical and Pharmacological Bulletin (Tokyo) 28 3449-3452.
52. Walker BR, Williams BC & Edwards CRW 1994 Regulation of 11β-hydroxysteroid dehydrogenase activity by the hypothalamic-pituitary-adrenal axis in the rat. Journal of Endocrinology 141 467-472.
53. Wang ZY, Agarwal R, Zhou ZC, Bickers DR & Mukhtar H 1991 Inhibition of mutagenicity in Salmonella typhimurium and skin tumor initiating and tumor promoting activities in SENCAR mice by glycyrrhetinic acid: comparison of 18 alpha- and 18 beta-stereoisomers. Carcinogenesis 12 187-192.
54. Yang K & Yu M 1994 Evidence for distinct isoforms of 11 beta-hydroxysteroid dehydrogenase in the ovine liver and kidney. Journal of Steroid Biochemistry and Molecular Biology 49 245-250.
55. Zhang YH, Yoshida T, Isobe K, Rahman SM, Nagase F, Ding L & Nakashima I 1990 Modulation by glycyrrhizin of the cell-surface expression of H-2 class I antigens on murine tumour cell lines and normal cell populations. Immunology 70 405-410.
56. Zhou F, Bouillard B, Pharaboz Joly MO & Andre J 1989 Non-classical antiestrogenic actions of dexamethasone in variant MCF-7 human breast cancer cells in culture. Molecular and Cellular Endocrinology 66 189-197.